Your browser doesn't support javascript.
loading
HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors.
Shen, Jiaming; Wang, Xia; Wang, Ningning; Wen, Shifei; Yang, Guangde; Li, Li; Fu, Juanjuan; Pan, Xiucheng.
Afiliação
  • Shen J; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Wang X; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Wang N; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Wen S; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Yang G; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Li L; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Fu J; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Pan X; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Front Cell Infect Microbiol ; 13: 1179689, 2023.
Article em En | MEDLINE | ID: mdl-37197205

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China